WildBrain Ltd. (TSX:WILD)

Verve Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	427	231	318	427	479	222
Market Cap Growth	65.38%	-27.51%	-25.44%	-10.85%	115.42%	-11.39%
Enterprise Value	1,199	1,038	1,167	1,203	1,241	1,064
Last Close Price	2.01	1.12	1.59	2.46	2.78	1.30
PE Ratio	-	-	-	75.72	-	-
Forward PE	81.31	-	21.20	16.40	93.29	-
PS Ratio	0.83	0.50	0.60	0.84	1.06	0.52
PB Ratio	2.38	0.94	0.98	1.35	1.58	0.65
P/FCF Ratio	2.48	3.17	3.40	14.19	4.66	1.78
P/OCF Ratio	2.47	3.14	3.38	12.90	4.53	1.70
EV/Sales Ratio	2.33	2.25	2.19	2.37	2.74	2.50
EV/EBITDA Ratio	16.13	9.57	11.33	15.08	18.06	16.38
EV/EBIT Ratio	22.05	10.98	13.26	18.69	22.50	20.78
EV/FCF Ratio	6.96	14.23	12.45	39.95	12.06	8.50
Debt / Equity Ratio	3.28	2.47	1.91	2.01	1.95	1.84
Debt / EBITDA Ratio	7.94	5.14	5.56	7.22	7.62	8.38
Debt / FCF Ratio	3.43	8.33	6.62	21.05	5.75	5.03
Asset Turnover	0.48	0.41	0.44	0.43	0.40	0.35
Inventory Turnover	2.26	1.51	1.94	2.17	2.19	2.10
Quick Ratio	1.13	0.79	1.09	0.84	1.09	1.15
Current Ratio	1.59	1.19	1.60	1.33	1.76	1.86
Return on Equity (ROE)	-55.45%	-28.10%	-5.47%	10.27%	7.17%	-49.63%
Return on Assets (ROA)	3.16%	5.21%	4.52%	3.43%	3.03%	2.60%
Return on Capital (ROIC)	3.98%	6.57%	5.81%	4.36%	3.69%	3.06%
Return on Capital Employed (ROCE)	7.70%	14.90%	10.20%	7.60%	6.30%	5.60%
Earnings Yield	-42.18%	-45.90%	-14.31%	1.32%	-1.48%	-106.11%
FCF Yield	40.33%	31.60%	29.43%	7.05%	21.48%	56.28%
Buyback Yield / Dilution	-5.22%	-16.07%	10.12%	-15.29%	-9.23%	-16.26%
Total Shareholder Return	-	-16.07%	10.12%	-15.29%	-9.23%	-16.26%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.